Zdrowie i gospodarka · 24/09/2010
NIH Seeks Exclusive License for Chikungunya Treatment
The National Institutes of Health is considering granting an exclusive license to Merck Sharp & Dohme Corp. to develop, manufacture, and sell treatments for Chikungunya infections, in accordance with US patent laws.